These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29545359)

  • 1. Defining the Outcome of Ventricular Tachycardia Ablation: Timing and Value of Programmed Ventricular Stimulation.
    Oloriz T; Baratto F; Trevisi N; Barbaro M; Bisceglia C; D'Angelo G; Yamase M; Paglino G; Radinovic A; Della Bella P
    Circ Arrhythm Electrophysiol; 2018 Mar; 11(3):e005602. PubMed ID: 29545359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive programmed ventricular stimulation early after ventricular tachycardia ablation to predict risk of late recurrence.
    Frankel DS; Mountantonakis SE; Zado ES; Anter E; Bala R; Cooper JM; Deo R; Dixit S; Epstein AE; Garcia FC; Gerstenfeld EP; Hutchinson MD; Lin D; Patel VV; Riley MP; Robinson MR; Tzou WS; Verdino RJ; Callans DJ; Marchlinski FE
    J Am Coll Cardiol; 2012 Apr; 59(17):1529-35. PubMed ID: 22516442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic Support in Ventricular Tachycardia Ablation: An International VT Ablation Center Collaborative Group Study.
    Turagam MK; Vuddanda V; Atkins D; Santangeli P; Frankel DS; Tung R; Vaseghi M; Sauer WH; Tzou W; Mathuria N; Nakahara S; Dickfeld TM; Bunch TJ; Weiss P; Di Biase L; Tholakanahalli V; Vakil K; Tedrow UB; Stevenson WG; Della Bella P; Shivkumar K; Marchlinski FE; Callans DJ; Natale A; Reddy M; Lakkireddy D
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1534-1543. PubMed ID: 29759835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial.
    Willems S; Tilz RR; Steven D; Kääb S; Wegscheider K; Gellér L; Meyer C; Heeger CH; Metzner A; Sinner MF; Schlüter M; Nordbeck P; Eckardt L; Bogossian H; Sultan A; Wenzel B; Kuck KH;
    Circulation; 2020 Mar; 141(13):1057-1067. PubMed ID: 32000514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term reproducibility of ventricular tachycardia induction with electrophysiological testing in patients with coronary heart disease and depressed left ventricular ejection fraction.
    Brembilla-Perrot B; Houriez P; Claudon O; Preiss JP; Beurrier D; Louis P; Terrier de la Chaise A
    Pacing Clin Electrophysiol; 2000 Jan; 23(1):47-53. PubMed ID: 10666753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive programmed stimulation in the setting of ventricular tachycardia catheter ablation.
    Frontera A; Prolic Kalinsek T; Hadjis A; Della Bella P
    J Cardiovasc Electrophysiol; 2020 Jul; 31(7):1828-1835. PubMed ID: 32329104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of cardiac magnetic resonance imaging and programmed ventricular stimulation in patients with frequent premature ventricular complexes undergoing radiofrequency ablation.
    Yokokawa M; Siontis KC; Kim HM; Stojanovska J; Latchamsetty R; Crawford T; Jongnarangsin K; Ghanbari H; Cunnane R; Chugh A; Pelosi F; Oral H; Morady F; Bogun F
    Heart Rhythm; 2017 Nov; 14(11):1695-1701. PubMed ID: 28688990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of repeat programmed ventricular stimulation at electrophysiology study for arrhythmia prediction after acute myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Pacing Clin Electrophysiol; 2014 Jul; 37(7):795-802. PubMed ID: 24666010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator.
    De Ferrari GM; Rordorf R; Frattini F; Petracci B; De Filippo P; Landolina M
    Europace; 2007 Dec; 9(12):1151-7. PubMed ID: 17947251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scar dechanneling: new method for scar-related left ventricular tachycardia substrate ablation.
    Berruezo A; Fernández-Armenta J; Andreu D; Penela D; Herczku C; Evertz R; Cipolletta L; Acosta J; Borràs R; Arbelo E; Tolosana JM; Brugada J; Mont L
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):326-36. PubMed ID: 25583983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation of scar-related ventricular tachycardia in patients with electrical storm using remote magnetic catheter navigation.
    Arya A; Eitel C; Bollmann A; Wetzel U; Sommer P; Gaspar T; Husser D; Piorkowski C; Hindricks G
    Pacing Clin Electrophysiol; 2010 Nov; 33(11):1312-8. PubMed ID: 20723092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Baseline Antiarrhythmic Drug on Outcomes With Ablation in Ischemic Ventricular Tachycardia: A VANISH Substudy (Ventricular Tachycardia Ablation Versus Escalated Antiarrhythmic Drug Therapy in Ischemic Heart Disease).
    Parkash R; Nault I; Rivard L; Gula L; Essebag V; Nery P; Tung S; Raymond JM; Sterns L; Doucette S; Wells G; Tang ASL; Stevenson WG; Sapp JL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005663. PubMed ID: 29305400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Noninducibility on Outcomes of Ventricular Tachycardia Ablation: A VANISH Substudy.
    Essebag V; Joza J; Nery PB; Doucette S; Nault I; Rivard L; Gula L; Deyell M; Raymond JM; Lane C; Sapp JL
    JACC Clin Electrophysiol; 2018 Jul; 4(7):911-919. PubMed ID: 30025692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive Programmed Ventricular Stimulation-Guided Management Following Ventricular Tachycardia Ablation.
    Muser D; Hayashi T; Castro SA; Supple GE; Schaller RD; Santangeli P; Arkles J; Kumareswaran R; Nazarian S; Deo R; Lin D; Dixit S; Epstein AE; Callans DJ; Marchlinski FE; Frankel DS
    JACC Clin Electrophysiol; 2019 Jun; 5(6):719-727. PubMed ID: 31221360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter Ablation of Ventricular Tachycardia as the First-Line Therapy in Patients With Coronary Artery Disease and Preserved Left Ventricular Systolic Function: Long-Term Results.
    Clemens M; Peichl P; Wichterle D; Pavlů L; Čihák R; Aldhoon B; Kautzner J
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1105-10. PubMed ID: 26179108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.
    Carbucicchio C; Santamaria M; Trevisi N; Maccabelli G; Giraldi F; Fassini G; Riva S; Moltrasio M; Cireddu M; Veglia F; Della Bella P
    Circulation; 2008 Jan; 117(4):462-9. PubMed ID: 18172038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients.
    Acosta J; Cabanelas N; Penela D; Fernández-Armenta J; Andreu D; Borràs R; Korshunov V; Cabrera M; Vasanelli F; Arbelo E; Guasch E; Martínez M; Tolosana JM; Mont L; Berruezo A
    Europace; 2017 Jun; 19(6):976-982. PubMed ID: 27353322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.